menu
    • menu

    Company profile for Cidara Therapeutics

    Pfanstiehl, a global leader in the manufacture of cGMP high purity, low endotoxin, low metals (HPLE-LM)TM injectable grade excipients.

    Virtual Booth

    Contact Supplier

    Global Pharma Healthcare: Setting the global benchmark in quality, innovation, and care

    Virtual Booth

    Contact Supplier

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    Phyton is a World Leader in Plant Cell Fermentation Technology and Commercial Manufacturing.

    Virtual Booth

    Contact Supplier

    Farmak works in the development, production and marketing of APIs, Intermediates & Specialties// FDA inspected.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Cidara is developing therapeutics to improve the standard of care for patients facing severe fungal or viral infections. The Company’s portfolio is comprised of breakthrough approaches aimed at transforming existing treatment and prevention paradigms, first with its lead antifungal candidate, rezafungin, in addition to therapies targeting influenza and other viral diseases from Cidara’s proprietary Cloudbreak® platform. C...
    Cidara is developing therapeutics to improve the standard of care for patients facing severe fungal or viral infections. The Company’s portfolio is comprised of breakthrough approaches aimed at transforming existing treatment and prevention paradigms, first with its lead antifungal candidate, rezafungin, in addition to therapies targeting influenza and other viral diseases from Cidara’s proprietary Cloudbreak® platform. Cidara is headquartered in San Diego, California.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Cidara TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    6310 Nancy Ridge Drive, Suite 101 San Diego, CA 92121
    Telephone
    Telephone
    (858) 752-6170
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.cidara.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/cidara-therapeutics/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/CidaraThera

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Merck To Complete Acquisition Of Cidara Therapeutics
    Merck To Complete Acquisition Of Cidara Therapeutics

    07 Jan 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-01-07/merck-to-complete-acquisition-of-cidara-therapeutics

    PHARMIWEB
    07 Jan 2026
    Share Share
    Cidara Completes Ph3 ANCHOR Enrollment For CD388 Flu Prevention
    Cidara Completes Ph3 ANCHOR Enrollment For CD388 Flu Prevention

    24 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/24/3193451/0/en/Cidara-Therapeutics-Reaches-Target-Enrollment-of-Phase-3-ANCHOR-Trial-Evaluating-CD388-for-Prevention-of-Seasonal-Influenza-in-High-Risk-Populations.html

    GLOBENEWSWIRE
    24 Nov 2025
    Share Share
    Merck to Acquire Cidara Therapeutics
    Merck to Acquire Cidara Therapeutics

    14 Nov 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251114185276/en/Merck-to-Acquire-Cidara-Therapeutics-Inc.-Diversifying-Its-Portfolio-to-Include-Late-Phase-Antiviral-Agent

    BUSINESSWIRE
    14 Nov 2025
    Share Share
    Cidara Pharma Updates On Corporate Progress And Q3 2025 Finances
    Cidara Pharma Updates On Corporate Progress And Q3 2025 Finances

    06 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/06/3183153/0/en/Cidara-Therapeutics-Provides-Corporate-Update-and-Reports-Third-Quarter-2025-Financial-Results.html

    GLOBENEWSWIRE
    06 Nov 2025
    Share Share
    Cidara Therapeutics Joins November Investor Conferences
    Cidara Therapeutics Joins November Investor Conferences

    28 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/28/3175321/0/en/Cidara-Therapeutics-to-Participate-in-November-Investor-Conferences.html

    GLOBENEWSWIRE
    28 Oct 2025
    Share Share
    Cidara Therapeutics To Host Q3 2025 Financial Results Conference
    Cidara Therapeutics To Host Q3 2025 Financial Results Conference

    23 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/23/3172428/0/en/Cidara-Therapeutics-to-Report-Third-Quarter-2025-Financial-Results-and-Host-Quarterly-Conference-Call-on-November-6-2025.html

    GLOBENEWSWIRE
    23 Oct 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search